Tinidazole

Tinidazole

SCHEMBL21141

CCS(=O)(=O)CCn1c([N+](=O)[O-])cnc1C

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 4/20 1.00
▸ SMN1; SMN2 Q16637 1/20 1.00
▸ CA1 P00915 7/20 0.74
▸ CA2 P00918 7/20 0.74
▸ CA9 Q16790 7/20 0.74
▸ MAPK1 P28482 2/20 0.64
▸ ALDH1A1 P00352 2/20 0.64
▸ THRB P10828 1/20 0.64
▸ TSHR P16473 1/20 0.64
▸ CA12 O43570 6/20 0.61
▸ GLA P06280 1/20 0.54
▸ ATM Q13315 1/20 0.54
▸ GAA P10253 1/20 0.51
▸ CHRM1 P11229 1/20 0.50
▸ KMT2A Q03164 1/20 0.50
▸ EGFR P00533 3/20 0.49
▸ ERBB2 P04626 3/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Tinidazole SCHEMBL14742527 1.00 LMNA (1.00) LMNASMN1; SMN2CA1CA2CA9
Tinidazole SCHEMBL27877209 0.99 LMNA (0.97) LMNASMN1; SMN2CA1CA2CA9
Tinidazole SCHEMBL27640947 0.99 LMNA (0.97) LMNASMN1; SMN2CA1CA2CA9
Tinidazole SCHEMBL27865473 0.97 LMNA (0.94) LMNASMN1; SMN2CA1CA2CA9
Tinidazole SCHEMBL28888098 0.96 LMNA (0.92) LMNASMN1; SMN2CA1CA2CA9
SCHEMBL11579155 0.94 LMNA (0.89) LMNASMN1; SMN2CA1CA2CA9
Tinidazole SCHEMBL19149564 0.93 LMNA (0.87) LMNASMN1; SMN2CA1CA2CA9
SCHEMBL11521582 0.90 LMNA (0.82) LMNASMN1; SMN2CA1CA2CA9
Dapsone SCHEMBL2637089 0.88 LMNA (0.77) LMNASMN1; SMN2CA1CA2CA9
SCHEMBL11581585 0.87 CA1 (0.76) LMNASMN1; SMN2CA1CA2CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 17974 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4739326-A2 PRODUCTION & SECRETION OF AUXIN-LIKE MOLECULES IN BACTERIA SNIPR Biome ApS (DK) 2026-05-13 — — EP claimed
EP-3648778-B1 HIGH POTENCY STABLE FORMULATIONS OF VAGINAL LACTOBACILLUS OSEL INC (US) 2026-05-13 — — EP claimed
EP-4255391-B1 LUMINOL FOR USE IN THE TREATMENT OF SEQUELAE OF A SARS-COV-2 INFECTION METRIOPHARM AG (CH) 2026-05-06 — — EP claimed
US-20260115234-A1 PRODUCTION & SECRETION OF AUXIN-LIKE MOLECULES IN BACTERIA SNIPR BIOME APS (DK) 2026-04-30 — — US claimed
US-20260108619-A1 CONJUGATION LINKERS, CELL BINDING MOLECULE-DRUG CONJUGATES CONTAINING THE LINKERS, METHODS OF MAKING AND USES SUCH CONJUGATES WITH THE LINKERS HANGZHOU DAC BIOTECH CO., LTD. (CN) 2026-04-23 — — US claimed
US-20260098047-A1 Anti-Giardial Compounds COMMW SCIENT IND RES ORG (AU) 2026-04-09 — — US claimed
EP-4434588-B1 AEROSOL DELIVERY DEVICE PARI PHARMA GMBH (DE) 2026-04-08 — — EP claimed
US-20260091119-A1 ISOLATED TARGETED DELIVERY SYSTEM FOR THE TREATMENT OF GLIOMA CELLIS AG (CH) 2026-04-02 — — US claimed
EP-4709404-A1 INTRAVAGINAL FORMULATIONS OF GARDNERELLA ENDOLYSINS BioNTech SE (DE) 2026-03-18 — — EP claimed
US-12576124-B2 Formulation of a conjugate of a tubulysin analog to a cell-binding molecule HANGZHOU DAC BIOTECH CO., LTD (CN) 2026-03-17 — — US claimed
WO-1992003133-A1 TOPICAL TREATMENT OF BLEPHARITIS BLOOM, LEONARD (US) 1992-03-05 — — WO claimed
EP-0304374-B1 THERAPEUTICAL PREPARATION CONTAINING COLLAGEN AND IMIDAZOLE DERIVATIVES SEPTODONT (FR) 1992-01-08 — — EP claimed
EP-0462631-A1 Methods and compositions for the treatment of gastrointestinal disorders Marshall, Barry James, Dr. (US) 1991-12-27 — — EP claimed
US-4957918-A Topical treatment of blepharitis Bloom, Leonard (US) 1990-09-18 — — US claimed
EP-0222834-A4 TREATMENT OF NON-ULCER DYSPEPSIA WITH BISMUTH SALTS. BORODY THOMAS J 1989-10-04 — — EP claimed
US-4837154-A AQUEOUS PREPARATION OF GELLING AGENTS AND NUTRIENT BROTH WISCONSIN ALUMNI RESEARCH FOUNDATION (US) 1989-06-06 — — US claimed
EP-0304374-A1 Therapeutical preparation containing collagen and imidazole derivatives SEPTODONT (FR) 1989-02-22 — — EP claimed
EP-0222834-A1 TREATMENT OF NON-ULCER DYSPEPSIA WITH BISMUTH SALTS THE PROCTER & GAMBLE COMPANY (US) 1987-05-27 — — EP claimed
WO-1986005981-A1 TREATMENT OF NON-ULCER DYSPEPSIA WITH BISMUTH SALTS BORODY THOMAS J 1986-10-23 — — WO claimed
US-4119723-A NITROIMIDAZOLES Simoons, John R. A. (US) 1978-10-10 — — US claimed
Send feedback